Perceptive Advisors Llc - Significant Ownership

Signature - Title
/s/ Joseph Edelman - Joseph Edelman, Managing Member
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Perceptive Advisors Llc.

Significant Ownership of Perceptive Advisors Llc

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ADGM Adagio Medical Holdings, Inc. Common Stock, $0.0001 par value per share 73.6% $11.8M 15.3M Perceptive Advisors LLC Dec 31, 2024
TRIB Trinity Biotech plc Class A Ordinary Shares, $0.0001 par value per share 22.5% $105M $15.6M 101M +17.5% Perceptive Advisors LLC Oct 23, 2025
SLDB Solid Biosciences Inc. Common Stock, $0.001 par value per share 15.6% $32.2M 11.9M Perceptive Advisors LLC Feb 19, 2025
LYRA Lyra Therapeutics, Inc. Common Stock, $0.001 par value 15.55% $22.2K 256K Perceptive Advisors LLC Aug 12, 2025
ATXS Astria Therapeutics, Inc. Common Stock, par value $0.001 per share 11.5% $47.2M 6.49M Perceptive Advisors LLC Oct 14, 2025
NAUT Nautilus Biotechnology, Inc. Common Stock, $0.0001 par value per share 10.1% $8.84M $152K 12.8M +1.75% Perceptive Advisors LLC Jun 20, 2025
ENGN enGene Holdings Inc. Common Shares 9.99% $47.1M 6.77M Perceptive Advisors LLC Nov 11, 2025
OBIO Orchestra BioMed Holdings, Inc. Common Stock, par value $0.0001 per share 9.99% $14.1M 5.68M Perceptive Advisors LLC Sep 30, 2025
PALI PALISADE BIO, INC. Common Stock, $0.01 par value 9.99% $7.1M 12.2M Perceptive Advisors LLC Oct 2, 2025
IRD Opus Genetics, Inc. Common Stock, $0.0001 par value per share 9.99% $4.01M 4.51M Perceptive Advisors LLC Mar 24, 2025
TRAW Traws Pharma, Inc. Common Stock, par value $0.01 per share 9.99% $1.68M $646K 887K +62.7% Perceptive Advisors LLC Sep 30, 2025
OM Outset Medical, Inc. Common Stock, $0.001 par value per share 9.5% $3.16M 5.63M Perceptive Advisors LLC Jan 8, 2025
ALDX Aldeyra Therapeutics, Inc. Common Stock, par value $0.001 per share 8.7% $27.3M $6.11M 5.22M +28.9% Perceptive Advisors LLC Sep 30, 2025
AMLX Amylyx Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 8.2% $122M $14.7M 8.95M +13.7% Perceptive Advisors LLC Sep 30, 2025
IVVD INVIVYD, INC. Common Stock, $0.0001 par value per share 7.9% $40.7M 21.8M Perceptive Advisors LLC Nov 18, 2025
XFOR X4 PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share 7.6% $21M 6.06M Perceptive Advisors LLC Oct 27, 2025
ANRO Alto Neuroscience, Inc. Common Stock, $0.0001 par value per share 7.3% $7.72M 1.99M Perceptive Advisors LLC Oct 3, 2025
RYTM Rhythm Pharmaceuticals, Inc. Common Stock, $0.001 par value per share 6.8% $208M 4.42M Perceptive Advisors LLC Mar 31, 2025
OM Outset Medical, Inc. Common Stock, $0.001 par value per share 6.7% $12.3M 1.21M Perceptive Advisors LLC Mar 31, 2025
PRAX Praxis Precision Medicines, Inc. Common Stock, par value $0.0001 per share 6.69% $53.1M $14.9M 1.36M +38.9% Perceptive Advisors LLC Jul 15, 2025
CELC Celcuity Inc. Common Stock, $0.001 par value per share 6.55% $29.5M $11.5M 2.67M +63.5% Perceptive Advisors LLC Jul 30, 2025
DRUG Bright Minds Biosciences Inc. Common Shares, without par value 6.3% $16M 445K Perceptive Advisors LLC Mar 31, 2025
CTMX CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share 5.9% $19.4M 9.68M Perceptive Advisors LLC Aug 14, 2025
TVTX TRAVERE THERAPEUTICS, INC. Common Stock, par value $0.0001 per share 5.5% $117M 4.9M Perceptive Advisors LLC Oct 6, 2025
BDSX Biodesix, Inc. Common Stock, par value $0.001 per share 5.1% $4.37M $570K 7.67M +15% Perceptive Advisors LLC May 12, 2025
IVA Inventiva S.A. Ordinary shares, nominal value euro 0.01 per share 4.99% $40.3M $9.63M 7.3M +31.4% Perceptive Advisors LLC Sep 30, 2025
AVR Anteris Technologies Global Corp. Common Stock, par value $0.0001 per share 4.7% $6.31M -$2.72M 1.71M -30.1% Perceptive Advisors LLC Jun 30, 2025
ACLX Arcellx, Inc. Common Stock, par value $0.001 per share 4.5% $184M -$33.2M 2.48M -15.3% Perceptive Advisors LLC Jun 30, 2025
RAPT RAPT Therapeutics, Inc. Common Stock, $0.0001 par value per share 4.5% $5M 5.88M Perceptive Advisors LLC Dec 31, 2024
EWTX Edgewise Therapeutics, Inc. Common Stock, par value $0.0001 per share 4.4% $68M -$25.7M 4.64M -27.5% Perceptive Advisors LLC Jun 30, 2025
SYRE Spyre Therapeutics, Inc. Common Stock, $0.0001 par value per share 4.4% $31.5M -$186M 2.57M -79.6% Perceptive Advisors LLC Dec 31, 2024
AORT ARTIVION, INC. Common Stock, $0.01 par value 4.3% $85.5M 2.02M Perceptive Advisors LLC Sep 30, 2025
IOVA Iovance Biotherapeutics, Inc. Common Stock, par value $0.000041666 per share 3.8% $42.3M -$30.7M 12.8M -42.1% Perceptive Advisors LLC Mar 31, 2025
EOLS Evolus, Inc. Common Stock, $0.00001 par value per share 3.8% $18.8M -$12.5M 2.47M -40.1% Perceptive Advisors LLC Jun 30, 2025
ENSC Ensysce Biosciences, Inc. Common Stock, par value $0.0001 per share 3.7% $176K 86.7K 0% Perceptive Advisors LLC Mar 31, 2025
BBNX Beta Bionics, Inc. Common Stock, $0.0001 par value per share 3.68% $23.8M 1.59M Perceptive Advisors LLC Mar 31, 2025
CTNM Contineum Therapeutics, Inc. Class A Common Stock, par value $0.001 per share 3.2% $7.03M -$7.45M 699K -51.5% Perceptive Advisors LLC Jun 30, 2025
CRGX CARGO Therapeutics, Inc. Common Stock, $0.001 par value per share 2.5% $4.74M 1.17M Perceptive Advisors LLC Apr 23, 2025
FBRX Forte Biosciences, Inc. Common Stock, par value $0.001 per share 2.5% $875K 164K Perceptive Advisors LLC Dec 31, 2024
FOLD Amicus Therapeutics, Inc. Common Stock, par value $0.01 per share 2.4% $54.9M -$104M 7.41M -65.5% Perceptive Advisors LLC Jun 30, 2025
APLT Applied Therapeutics, Inc. Common Stock, $0.0001 par value per share 2.4% $915K 2.86M Perceptive Advisors LLC Dec 31, 2024
SRZN Surrozen, Inc. Common Stock, $0.0001 par value per share 1.9% $1.94M 167K 0% Perceptive Advisors LLC Mar 31, 2025
VRCA Verrica Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 1.6% $711K -$1.56M 1.48M -68.7% Perceptive Advisors LLC Mar 31, 2025
ACRV Acrivon Therapeutics, Inc. Common Stock, par value $0.001 per share 0% $0 -$4.13M 0 -100% Perceptive Advisors LLC Jun 2, 2025
VRNA Verona Pharma plc Ordinary shares, nominal value GBP 0.05 per share 0% $0 -$588M 0 -100% Perceptive Advisors LLC Sep 30, 2025
KALA KALA BIO, Inc. Common Stock, par value $0.001 per share 0% $0 -$860K 0 -100% Perceptive Advisors LLC Sep 30, 2025
LYRA Lyra Therapeutics, Inc. Common Stock, $0.001 par value 0% $0 -$596K 0 -100% Perceptive Advisors LLC Nov 21, 2025
TIL Instil Bio, Inc. Common Stock, par value $0.000001 per share 0% $0 0 Perceptive Advisors LLC Mar 31, 2025
OKUR OnKure Therapeutics, Inc. Common Stock, par value $0.0001 per share $0 0 Perceptive Advisors LLC Jun 30, 2025

Schedules 13D/G Reported by Perceptive Advisors Llc:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.